Takeda Agrees to $2.4 Billion Settlement in Actos Bladder Cancer Cases
Settlement In Actos Bladder Cancer Cases. Takeda Pharmaceuticals has agreed to pay $2.4 billion to settle thousands of lawsuits from patients and families who said Takeda’s diabetes drug Actos [...]